Ionis Pharmaceuticals (IONS) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to -$0.8.
- Ionis Pharmaceuticals' EPS (Weighted Average and Diluted) rose 1578.95% to -$0.8 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.69, marking a year-over-year increase of 3073.77%. This contributed to the annual value of -$3.04 for FY2024, which is 1875.48% down from last year.
- Latest data reveals that Ionis Pharmaceuticals reported EPS (Weighted Average and Diluted) of -$0.8 as of Q3 2025, which was up 1578.95% from $0.68 recorded in Q2 2025.
- In the past 5 years, Ionis Pharmaceuticals' EPS (Weighted Average and Diluted) registered a high of $1.59 during Q4 2021, and its lowest value of -$1.03 during Q3 2023.
- Over the past 5 years, Ionis Pharmaceuticals' median EPS (Weighted Average and Diluted) value was -$0.6 (recorded in 2023), while the average stood at -$0.46.
- In the last 5 years, Ionis Pharmaceuticals' EPS (Weighted Average and Diluted) plummeted by 107059.27% in 2024 and then skyrocketed by 25058.21% in 2025.
- Ionis Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at $1.59 in 2021, then plummeted by 123.52% to -$0.37 in 2022, then skyrocketed by 83.92% to -$0.06 in 2023, then plummeted by 1070.59% to -$0.7 in 2024, then fell by 13.9% to -$0.8 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.8 for Q3 2025, versus $0.68 for Q2 2025 and -$0.93 for Q1 2025.